-
PUBLICATION
2023.03.22
SMC is proud to announce that Hyogo Medical University (JPN) has published a study featuring histopathological data evaluated by our scientists here at SMC.
-
PUBLICATION
Study published in Cell Metabolism on the efficacy of MGAT2 inhibitor in STAM™
2023.03.15
SMC is proud to announce that Bristol-Myers Squibb (NJ) has published the results of their study using our pre-clinical services with the STAM™ model in Cell Metabolism.
-
NEWS RELEASE
March 9th is World Kidney Day!
2023.03.08
Today, in celebration of World Kidney Day, we would like to share with you a little bit about the campaigns history, as well as what the purpose of it is. World Kidney Day aims to raise awareness of the important role that the kidney plays, as well as reduce kidney disease and other related health problems. The campaign is an initiative run by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations – World Kidney Alliance (IFKF-WKA), where they host many different events around the world with the goal of increasing public understanding of how to prevent kidney disease, recognize its risk factors and live with it.
-
NEWS RELEASE
Introduction of Bile duct ligation (BDL)-induced primary biliary cirrhosis model
2023.03.02
Today, we would like to introduce our bile duct ligation (BDL)-induced primary biliary cirrhosis disease model.
-
PRODUCTS AND SERVICES
Introduction of bleomycin-induced SSc-ILD model
2023.02.22
Today, we would like to introduce a more clinically correlative model in which skin and lung fibrosis develop simultaneously.
-
NEWS RELEASE
Announcement of webinar 【Creating high quality non-clinical study designs based on clinical trials】
2023.02.15
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on February 16th (JST) from 10:30 AM.
-
PRODUCTS AND SERVICES
Introduction of positive control drug for kidney fibrosis mouse model
2023.02.08
Today, we would like to introduce an established positive control – an ALK5 inhibitor - for our Unilateral Ureteral Obstruction (UUO)-induced renal fibrosis model.
-
PRODUCTS AND SERVICES
Introduction of our experiences in histopathological analyses for IPF
2023.02.01
Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which is a clinically representative mouse model that can be used to conduct drug efficacy studies for idiopathic pulmonary fibrosis (IPF).
-
NEWS RELEASE
February 4th is World Cancer Day!
2023.01.25
World Cancer Day was established on February 4th, 2000, at the World Summit Against Cancer for the New Millennium in Paris initiated by UICC (Union for International Cancer Control).
-
PUBLICATION
Study on the efficacy of dietary supplements in the mdx mouse published in bioRxiv.
2023.01.19
SMC is proud to announce that GN Corporation (JPN) has published the results of their study using our pre-clinical services in bioRxiv.
-
NEWS RELEASE
SMC announces Announcement of webinar 【High quality non-clinical study designs】
2023.01.11
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place next week on January 19th (JST) from 10:30 AM.
-
NEWS RELEASE
NASH, the fastest growing cause of liver cancer
2023.01.05
We wish you a Happy and Prosperous New Year!
